Office of Compliance

This process is referred to as a “cross-reference”. FDA regulations provide that with authorization, information previously submitted to the FDA regarding chemistry, manufacturing, and control (CMC), as well as information regarding pharmacology and toxicity, may be incorporated by reference into a new IND submission. 21 CFR 312.23 (b) ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download